Statins (e.g., Atorvastatin)
Treatment for Coronary Artery Disease
Typical Dosage: Atorvastatin: 10-80mg daily
Effectiveness
88%
Safety Score
65%
Clinical Trials
1
Participants
1M
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
Atorvastatin: 10-80mg daily
Time to Effect
6-12 months for cardiovascular event reduction
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
25(Treat 25 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10000(Treat 10000 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$40
Monitoring:$150
Side Effect Mgmt:$50
Total Annual:$240
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$15,000/QALY
QALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$800
Comparison vs No Treatment
Cost Difference
+$240/year
More expensive
QALY Difference
+0.30 QALYs
Better outcomes
Dominance
No dominance
Statins (e.g., Atorvastatin) Outcomes
for Coronary Artery Disease
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+30%
Common Side Effects
Myalgia (muscle pain)
+8%
Elevated liver enzymes
+2%
New-onset diabetes
+0.5%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Statins (e.g., Atorvastatin) in Coronary Artery Disease
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
NCT01013103COMPLETEDPHASE4
72 participants
INTERVENTIONAL
Athens, Greece
Started: Oct 1, 2007